Sanofi US announced this week new collaborations in type 2 diabetes management.
Sanfoli will be working with Duke Clinical Research Institute (DCRI) and the Center for Assessment Technology and Continuous Health (CATCH) on separate projects involving type 2 diabetics and medication management
"The results of this very innovative approach to using all available data, including non-traditional health care data, will help to direct the deployment of ever more personalized engagement programs, practical tools and services to enable people living with diabetes to engage more proactively with their treatment and thus achieve more satisfying outcomes," Sanofi Global Diabetes Integrated Care VP Dr. Peter Juhn said.
DCRI will work with methods to forecast the patients' medication adherence. CATCH will focus on ways to help patients and health care professionals decide on the best care plan to manage the patients' conditions. In the collaborations, the partners will look at non-traditional data that can help design patient outreach that promotes prescription adherence. The data may include prescription refill, social and geographic information as well as behavioral indicators that may interfere with the patients' ability to follow their treatment plan.
"CATCH's focus on integrative analytics and phenotypes will allow patients and health care professionals to make better informed and more tailored, effective decisions," CATCH's Co-Founder and Director Dr. Dennis Ausiello said. "Collaborations like this will help ensure our work is brought to the discovery and development process far sooner than was ever before possible."